Showing 1,621 - 1,640 results of 124,116 for search '(( 10 ((nn decrease) OR (mean decrease)) ) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 1.74s Refine Results
  1. 1621

    SPL treatment decreases diabetes-induced decrement in protein expression of cldn-5 in glomeruli (GL) and cldn-2 and occldn in proximal tubules (PT). by Eduardo Molina-Jijón (4020464)

    Published 2017
    “…<p>SPL prevents diabetes-induced decrease of cldn-5 protein expression (A and B) in GL, and mRNA (F) and protein expression of cldn-2 (A and C), and protein expression of occldn (A and D) in PT (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s002" target="_blank">S2 Fig</a>). …”
  2. 1622
  3. 1623
  4. 1624
  5. 1625
  6. 1626
  7. 1627

    CNP decrease mitochondrial membrane potential and induce mitochondrial fragmentation in melanoma cells. by Elif Aplak (7430123)

    Published 2020
    “…C, Quantification of melanoma and melanocyte mitochondrial morphology after treatment with CNP or CCCP for 24 h according to Duvezin-Caubet et al. [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0227926#pone.0227926.ref047" target="_blank">47</a>]: tubular (>5 μm), intermediate (0.55 μm), fragmented (< 0.5 μm). …”
  8. 1628
  9. 1629

    EphA4 immunostaining is decreased adjacent to injury site in ephrin-A5-Fc treated mice. by Yona Goldshmit (205708)

    Published 2011
    “…<p>Immunohistochemical analysis of (A,B) GFAP, (C–F) EphA4 and (G,H) CSPG expression at 2 weeks after spinal cord hemisection and 2 weeks of ephrin-A5-Fc treatment indicated that there was robust GFAP staining in both treated and control mice (A,B). …”
  10. 1630
  11. 1631
  12. 1632
  13. 1633
  14. 1634
  15. 1635

    Sarcopenia as an Independent Risk Factor for Decreased BMD in COPD Patients: Korean National Health and Nutrition Examination Surveys IV and V (2008-2011) by Dong-Won Lee (2208223)

    Published 2016
    “…<div><p>Background</p><p>A decrease in bone mineral density (BMD) is a systemic consequence of chronic obstructive pulmonary disease (COPD). …”
  16. 1636
  17. 1637
  18. 1638
  19. 1639
  20. 1640